Navigation Links
UV Technologies, Makers of UV-Aid, Predict H7N9 Bird Flu Cases Will Subside in Northern Hemisphere as Available Daylight Increases
Date:4/29/2013

Fort Myers, FL (PRWEB) April 29, 2013

The need for new and innovative approaches to combat an increasingly cunning and effective killer with new technologies like UV-Aid is becoming more necessary and vital. With over twenty deaths and hundreds more infected, H7N9 has now spread to Taiwan and the World Health Organization (WHO) has recently stated, “The potential development of human-to-human spread cannot be ruled out.”

While past research on the effects of sun exposure has focused on its negative aspects, recent trends in the field have begun to highlight the many positive effects that ultraviolet (UV) rays can have for human health. In fact, according to a paper published by the National Institutes of Health (NIH), there is a markedly larger annual disease burden as a result of lack of UV exposure than there is as a result of overexposure (approximately 3.3 billion in disability-adjusted life years compared to just 1.6 million). In addition, sun exposure is a known treatment for rickets and TB as a result of vitamin D production. As a consequence of this and other research, many scientists and health centers have begun to look into the benefits of UV exposure.

According to WHO data, it can also be inferred that exposure to UV could play a direct role in cases of influenza. Available sunlight has played a key role in cases of prevention over the past several decades – research shows that reported rates of influenza regularly drop to 1-2% of the population during periods of maximum sunlight. In fact, the WHO has reported that all cases of flu pandemics in tropical regions such as India and Thailand occur during their monsoon seasons, when sunlight exposure is at its lowest. This data strongly suggests that increasing UV exposure could result in influenza prevention.

According to Kevin McGuire, President of UV Technologies, "The migration of the flu is as predictable as flowers budding in the spring and leaves changing in the fall. The progression of H7N9 should be just as predictable." As China heads into summer the cases of flu in that country and region will subside and will most likely reappear in the southern hemisphere in places like Australia where available sunlight is about to reach its annual low on June 21. These events will likely occur without the involvement of a vaccine for H7N9 that does not exist at this time.

UV Technologies research points to sunlight as the missing piece in the influenza puzzle.
In light of governmental and international research on the cost of cases and treatment of influenza paired with acclaimed research on the proven benefits of UV exposure, UV-Aid is a dramatically innovative approach with the possibility to radically change how we treat the epidemic. Tests of UV-Aid have shown that UVA light exposure in nasal passages effectively kills germs present - a key component in preventing the influenza process. Over two years of UV-Aid trials have corroborated these results, along with data supporting the theory that increased sunlight exposure has a direct result in preventing cases of the flu.

Natural preventative measures such as supplementing natural sunlight exposure are highly supported to have the potential to prevent millions of cases of influenza each year. This could also result in a significant reduction of the misuse of antibiotics; reducing the threat of developing super bugs and additionally saving scores of lives and billions of dollars each year.

About UV Technology, LLC:

UV Technologies, LLC’s mission is to provide the best and most innovative products for customers’ health and well-being using natural processes to aid immune responses. UV-Aid helps prevent colds, flu, sore throats, sinus, and ear infections through the process of photo-oxidation. UV Technologies goal is to offer the safest and most innovative products for its customers to live a healthier, more productive life.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10677196.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Albright Technologies, the Leader in Medical Silicone Molding, Appoints New President
2. Research and Markets - Drug Delivery in Cancer - Technologies, Markets and Companies - 2013 Report
3. Great HealthWorks, Inc., makers of Omega XL, Report New Independent Study: Omega-3 DHA Protects Against Liver Disease
4. In Light of Alleged Deceptive Marketing Claims Made by Drug Makers, Parker Waichman LLP Addresses Issues Allegedly Related to the Safety and Effectiveness of Plavix
5. Web Entrepreneur Launches JuicersAndCoffeeMakers.com, a Website Featuring Quality Kitchen Appliances
6. Drug Makers Get EU Complaint over Generic Fentanyl Delay: Now, AttorneyOne Can Provide Advice for Legal Counsel in Case of Side Effects
7. Ordinary heart cells become biological pacemakers with injection of a single gene
8. Caddy Products, LLC, Makers of FaceCaddy Therapeutic Ice and Heat Wrap, Launches EyesCaddy and BackCaddy to Address Sinus Pain, Migraines and Back Pain.
9. Marketing Xocolate International Corp (MXI Corp) Makers of Xocai Healthy Dark Chocolate, Featured in Direct Selling News Spotlighting the Company's Continued Growth
10. AGA members tell lawmakers -- stop the cuts
11. Device Offers Hope for Battery-Free Pacemakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: